This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovations of Marc R. Gastonguay
Introduction
Marc R. Gastonguay is an accomplished inventor based in Tariffville, CT (US). He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory bowel disease. His innovative approach has the potential to improve patient outcomes through personalized treatment strategies.
Latest Patents
Marc R. Gastonguay holds a patent for a method of treating inflammatory bowel disease. This invention provides methods for identifying patients who do not adequately respond to vedolizumab therapy. It also outlines a personalized treatment approach using vedolizumab, which can enhance the effectiveness of the therapy for these patients. He has 1 patent to his name.
Career Highlights
Marc is currently associated with Takeda Pharmaceutical Company Limited, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication to research have positioned him as a valuable asset in his field.
Collaborations
Marc has collaborated with notable colleagues, including Maria Rosario and Morris Barocas. Their combined efforts contribute to the advancement of medical treatments and innovations.
Conclusion
Marc R. Gastonguay exemplifies the spirit of innovation in the medical field. His work on personalized treatment approaches for inflammatory bowel disease showcases the impact that dedicated inventors can have on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile